鼻内镜下鼻窦炎合并中鼻甲外侧壁切除术的临床疗效观察

目的:探讨鼻内镜下行鼻窦炎手术同时行中鼻甲外侧壁切除的疗效。方法:选择本院2009年6月至2013年7月的行鼻内镜下鼻窦炎手术的慢性鼻窦炎患者160例,随机分为观察组和对照组.对照组行单纯的鼻窦炎开放手术,观察组在对照组治疗的基础上行中鼻甲外侧壁切除术。比较两组术后临床疗效、换药平均次数、SNOT-20评分及不良反应等。结果:对照组术后平均换药次数显著高于观察组(P0.05);对照组治疗总有效率为72.50%,显著低于观察组92.50%,差异具有统计学意义(P0.01);两组治疗前SNOT-20评分比较无统计学差异(P0.05),治疗后SNOT-20评分,组内比较均低于治疗前(P0.05);观察组治疗后SNOT-20总分显著低于对照组(P0.05);两组不良反应发生率无显著差异(P0.05)。结论:鼻内镜下鼻窦炎手术中实施中鼻甲外侧壁切除的临床疗效显著,既不破坏鼻腔解剖结构,又保证了中鼻道的宽大,安全性较高,值得在临床推广应用。

Clinical Efficacy of Lateral Wall Resection of Middle Turbinate Combined with Sinusitis by Endoscope

Objective:To explore the clinical efficacy of lateral wall resection of middle turbinate combined with the endoscopic sinusitis surgery.Methods:160 patients who were undertaken the endoscopic sinusitis surgery were selected and randomly divided into the control group and the observation group. The patients in the control group were treated by the open surgery, while the patients in the observation group were conducted by the lateral wall resection of middle turbinate besides the control''s. Then the average frequency of postoperative dressing, the rate of total efficacy, the SNOT-20 score and the adverse reactions after the treatment of the patients in the two groups were observed and compared.Results:The average frequencies of post-operative dressing of the control group were significantly higher than that of the observation group (P<0.05); The rate of total efficacy in the control group was 72.50% which was lower than 92.50%in the observation group with statistically significant differences (P<0.01). There was no significant difference in SNOT-20 score between the two groups before the treatment (P>0.05); The SNOT-20 score of the observation group after treatment was significantly lower than that of the control group (P<0.05). There was no significant difference about the adverse reactions in the two groups(P>0.05).Conclusion:Endoscopic sinus surgery has significant clinical efficacy and safety on the treatment of lateral wall resection in the middle turbinate, so it is worthy of clinical promotion.